Rev Bras Oftalmol.2022;81:e0057

Color retinography as a means of screening for diabetic retinopathy in the tertiary hospital of Unified Health System

Julia Quadri , Paulo Caldas , Egídio , Cássio Freitas da , Helena Messinger

DOI: 10.37039/1982.8551.20220057

ABSTRACT

Objective

To evaluate the impact of diabetic retinopathy (DR) screening using color retinography in diabetic patients.

Methods

Retrospective descriptive study, evaluating reports of all retinographs performed since the implementation of the protocol for screening for diabetic retinopathy in diabetic patients followed up at the endocrinology outpatient clinic of a tertiary hospital of the Unified Health System, from May 2018 to May 2020.

Results

727 diabetic with age range from 14 to 91 years old, the majority being 60 years old or older (53.2%), female (68%) and white (87.6%), patients underwent retinography. Of the patients, 467 (64.2%) did not have DR, 125 (17.2%) had non-proliferative DR, 37 (5.1%) had severe non-proliferative DR and/or suspected macular edema, 65 (8.9%) had proliferative DR, 21 (2.9%) had suspicion signs of other pathologies and 12 (1.7%) had unsatisfactory images. A total of 114 (15.68%) patients were considered at high risk (those with severe non-proliferative NP and/or EM, proliferative DR or poor image) and were referred for comprehensive ophthalmic evaluation.

Conclusion

The screening of RD with color retinography enabled the detection of high-risk diabetic patients who needed assistance sooner and enabled their access to ophthalmologic consultation, which decreased disease morbidity. The others were referred to primary care for regulation through the Regulation System (SISREG).

Color retinography as a means of screening for diabetic retinopathy in the tertiary hospital of Unified Health System

Comments (0)